Company
Vitrolife
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
14
510(k), De Novo and PMA
Device trials
8
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
Recall records
2
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Vitrolife, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Vitrolife.
Latest FDA decisions
The 8 newest of 14 since 2015.
K243373 · Decided Jul 23, 2025 · 266 days after receipt
Device type: Catheter, Assisted Reproduction (MQF) · Obstetrics & Gynecology
K241662 · Decided Aug 30, 2024 · 81 days after receipt
Device type: Transducer, Ultrasonic, Diagnostic (ITX) · Radiology & Imaging
- Ultra RapidWarm Blast510(k)
K240605 · Decided Aug 7, 2024 · 156 days after receipt
Device type: Media, Reproductive (MQL) · Obstetrics & Gynecology
11 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- eValuating iDA Selection Ability. The VISA Study.Pivotal-lookingCompleted
NCT04969822 · 1,066 participants · Start Feb 20, 2020 · Primary completion Jan 24, 2023
Device: iDAScore® · For: IVF; Infertility
Sites: Sydney, Australia; Alexandria, Australia; Benowa, Australia · 14 sites in all
- Comparing KIDScore™ D5 and iDAScore®. The KiDA StudyPivotal-lookingCompleted
NCT04956848 · 165 participants · Start Oct 6, 2021 · Primary completion Nov 14, 2023
Device: iDAScore® · For: IVF; Infertility
Sites: Gothenburg, Sweden; Örebro, Sweden
- G-IVF and Sperm ParametersPivotal-lookingStatus unknown
NCT05597631 · 118 participants (planned) · Start Oct 2023 · Primary completion Mar 2024
Device: G-IVF PLUS · For: Infertility, Male
Sites: Marousi, Greece
5 more trials with a free account
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1448-2015 · Started Dec 22, 2014 · Posted by FDA Apr 15, 2015
Reason given: The firm is recalling three batches (FP14A09, FP14A10, FP14A11) of SpermMAR IgA test due to new formulation causing the motility of sperm cells to reduce in certain samples when the new bead solution was added.
Cause as FDA categorized it: Component design/selection · Device type: Reagent, Immunoassay, Igg (KTO)
Z-2795-2011 · Started May 12, 2011 · Posted by FDA Jul 12, 2011
Reason given: Precipitation observed in some bottles of Tham buffer used for adjusting pH of Perfadex prior to perfusion of donor lungs.
Cause as FDA categorized it: Process control · Device type: System And Accessories, Isolated Heart, Transport And Preservation (MSB)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.